AUTONOMIX MEDICAL, INC. Operating Expenses
AUTONOMIX MEDICAL, INC. (AMIX) reported Operating Expenses of $2.77 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-13
- AUTONOMIX MEDICAL, INC. operating expenses for the quarter ending 2026-06-30 was $2.77M, a 19.03% decline year-over-year.
- AUTONOMIX MEDICAL, INC. operating expenses for the quarter ending 2026-03-31 was $2.74M, a 15.84% decline year-over-year.
- AUTONOMIX MEDICAL, INC. operating expenses for the quarter ending 2025-12-31 was $3.34M, a 21.70% increase year-over-year.
- AUTONOMIX MEDICAL, INC. operating expenses for the quarter ending 2025-09-30 was $7.53M, a 165.66% increase year-over-year.
- AUTONOMIX MEDICAL, INC. operating expenses for fiscal 2026 was $17.03M, a 47.00% increase from fiscal 2025.
- AUTONOMIX MEDICAL, INC. operating expenses for fiscal 2025 was $11.59M, a 3.67% decline from fiscal 2024.
- AUTONOMIX MEDICAL, INC. operating expenses for fiscal 2024 was $12.03M, a 504.52% increase from fiscal 2023.
- AUTONOMIX MEDICAL, INC. operating expenses for fiscal 2023 was $1.99M.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.77M 10-Q · filed 2026-08-13 | $5.51M derived: sum of 2 quarters · filed 2026-08-13 | $8.85M derived: sum of 3 quarters · filed 2026-08-13 | $16.38M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $2.74M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-27 | $6.08M derived: sum of 2 quarters · filed 2026-05-27 | $13.61M derived: sum of 3 quarters · filed 2026-05-27 | $17.03M 10-K · filed 2026-05-27 |
| 2025-12-31 | $3.34M 10-Q · filed 2026-02-11 | $10.88M derived: sum of 2 quarters · filed 2026-02-11 | $14.30M 10-Q · filed 2026-02-11 | $17.55M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-09-30 | $7.53M 10-Q · filed 2025-11-12 | $10.96M 10-Q · filed 2025-11-12 | $14.21M derived: sum of 3 quarters · filed 2026-08-13 | $16.95M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $3.42M 10-Q · filed 2026-08-13 | $6.67M derived: sum of 2 quarters · filed 2026-08-13 | $9.42M derived: sum of 3 quarters · filed 2026-08-13 | $12.26M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $3.25M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-27 | $6.00M derived: sum of 2 quarters · filed 2026-05-27 | $8.84M derived: sum of 3 quarters · filed 2026-05-27 | $11.59M 10-K · filed 2026-05-27 |
| 2024-12-31 | $2.75M 10-Q · filed 2026-02-11 | $5.58M derived: sum of 2 quarters · filed 2026-02-11 | $8.34M 10-Q · filed 2026-02-11 | $10.75M derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-09-30 | $2.84M 10-Q · filed 2025-11-12 | $5.59M 10-Q · filed 2025-11-12 | $8.01M derived: sum of 3 quarters · filed 2025-11-12 | $10.93M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $2.75M 10-Q · filed 2025-08-13 | $5.17M derived: sum of 2 quarters · filed 2025-08-13 | $8.09M derived: sum of 3 quarters · filed 2025-08-13 | $13.91M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $2.42M derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-29 | $5.34M derived: sum of 2 quarters · filed 2025-05-29 | $11.16M derived: sum of 3 quarters · filed 2025-05-29 | $12.03M 10-K · filed 2025-05-29 |
| 2023-12-31 | $2.92M 10-Q · filed 2025-02-13 | $8.74M derived: sum of 2 quarters · filed 2025-02-13 | $9.61M 10-Q · filed 2025-02-13 | $10.27M derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-09-30 | $5.82M 10-Q · filed 2024-11-08 | $6.69M 10-Q · filed 2024-11-08 | $7.35M derived: sum of 3 quarters · filed 2024-11-08 | $7.89M derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | $871.00K 10-Q · filed 2024-08-13 | $1.53M derived: sum of 2 quarters · filed 2024-08-13 | $2.07M derived: sum of 3 quarters · filed 2024-08-13 | |
| 2023-03-31 | $657.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-31 | $1.20M derived: sum of 2 quarters · filed 2024-05-31 | $1.99M 10-K · filed 2024-05-31 | |
| 2022-12-31 | $544.00K 10-Q · filed 2024-02-13 | $1.33M 10-Q · filed 2024-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |